Report Categories
View AllRecent Articles
View All
CENN Cenntro Inc reports 422 YoY Q1 2026 revenue decline shares slide 448 in todays session
Dime Pref A DCOMP Volatility Analysis Q4 2025 EPS Exceeds Expectations
Nuveen NCDL Stock Investment Case Technical Strength 20260418
NuCana plc NCNA Stock Market Sentiment Analysis Q3 2024 Profit Exceeds Views
Is EUDA EUDA stock still a good play today Climbs Higher 20260422
NMP NMPAR Stock Target Price 179 20260424
Is Tri Pointe TPH stock moving unpredictably 004 20260420
Natural Gas Futures Decline as Weather Models Point to Milder Conditions
NextNRG NXXT Gains Attention as Renewable Energy Sector Seeks New Growth Drivers
Argentina Inflation Dips in April Offering Tentative Signs of Easing
Should You Sell MKS MKSI After 056 Drop 20260519
Nvidia and Apple Command Unprecedented Influence Over Stock Market
Gyrodyne LLC GYRO Climbs 331 Resistance at 802 in Focus 20260518
Adani Ports SEZ Delivers Substantial Returns Key Drivers and Market Outlook
Microns New Milestone Dicks Earnings and Paxtons Victory Over Cornyn Lead CNBC Morning Squawk
SpaceX Delays Starship Launch Amid Potential RecordBreaking IPO Plans
Trainline Raises FullYear Guidance for Second Time Citing Strong Demand
Hottest US Housing Market Emerges in a City That Has Shrunk for 75 Years
Endurance Technologies IPO Opens Key Details and Market Implications
UBER Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Holds Steady
TransMedics Q1 2026 Earnings EPS Misses Estimates by 52 as Revenue Data Unavailable
KN Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Over 4
Colony Bankcorp CBAN Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Modest Stock Gain
UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter
AWX Q4 2025 Earnings Narrowing Losses Amid Quiet Quarter
Corcept Therapeutics CORT Edges Higher as Stock Stabilizes Near Key Support
NVIDIA Edges Higher as Support Holds Steady
Cantor Equity Partners III CAEP Holds Steady at 150 Amid Consolidation
abrdn Global Infrastructure Income Fund ASGI Holds Near OneYear Low Amid Modest Selling Pressure
Vistagen Therapeutics VTGN Slides 155 as Traders Eye Critical Support at 061